The use of histoequivalent-bioplastic material for chronic foot ulcers on patients with diabetes

The main goal of this study was to improve the results of therapy in patients with chronic wounds on the foot in diabetics (I-II degree according to Wagner's classification) using histoequivalent bioplastic material «G-derm».Materials and methods. The study included 72 patients. The comparison group included 35 patients who underwent standard treatment with hydrocolloid dressings. The main group consisted of 37 patients. For them, in addition to standard treatment, the histoequivalent-bioplastic material «G-derm» was used. The patients' condition was assessed in dynamics on the 1st, 10th, 30th days from the start of treatment.Results. By the 30th day, the complete epithelialization was registered in 12 (16.7%) patients. The main group included 8 (21.6%) cases, and the control group - 4 (11.4%). The unsatisfactory epithelialization (healing less than a quarter of the initial area) by the 30th day of treatment was in 14 (19.4%) patients: in the main group - in 4 (10.9%) patients, in the comparison group - in 10 (28.5%) of patients. The remaining 25 (67.6%) patients in the main group and 21 (60%) participants in the comparison group had satisfactory epithelialization results by the 30th day of treatment.Conclusion. The results of this study show the effectiveness of using histoequivalent bioplastic material G-derm in local treatment of chronic wounds in patients with neuropathic diabetes in combination with standard therapies.The use of histoequivalent-bioplastic material in patients with diabetes leads to faster regeneration of the wound as well as increases the cases of complete epithelialization.